Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples

Abstract: The science for rapid treatment initiation for hepatitis C virus infection is in place. Easy and quick diagnostic tools can provide results within an hour. […]

The Present and Future of Colorectal Cancer Screening

Abstract: There have been multiple recent updates for recommendations pertaining to colorectal cancer (CRC) screening. Among the most notable is the recommendation from several guideline-issuing bodies […]

Management of Patients With Gastric Varices

Abstract: Management of patients with gastric varices represents a unique challenge for clinicians. The broad range of endoscopic and endovascular techniques currently available is in stark […]

Eosinophilic Gastrointestinal Diseases Beyond the Esophagus: An Evolving Field and Nomenclature

Abstract: The eosinophilic gastrointestinal diseases (EGIDs) are a group of chronic, immune-mediated gastrointestinal (GI) diseases characterized by GI symptoms and pathologic eosinophilic infiltration of specific areas […]

Hepatitis Delta: Current Knowledge and Future Directions

Abstract: Hepatitis delta virus (HDV) infection is caused by a unique circular RNA virus that relies on both the hepatitis B virus (HBV) antigen and human […]

Novel Therapies for Patients With Inflammatory Bowel Disease

Abstract: The implementation of biologic therapy has improved the treatment and clinical course of patients with inflammatory bowel disease since the initial approval of infliximab for […]

Review of Updated Hepatitis B Vaccine Recommendations and Potential Challenges With Implementation

Abstract: Hepatitis B virus (HBV) infection is a vaccine-preventable disease associated with substantial morbidity and mortality. Although safe and effective hepatitis B vaccines are available, an […]

COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety

Abstract: The COVID-19 pandemic, caused by SARS-CoV-2, has been the most significant global health crisis of the past century. The development of safe and effective vaccines […]

Biliary Tract Injury in Patients With COVID-19: A Review of the Current Literature

Abstract: Multiple studies and extensive clinical experience have shown that COVID-19 can impact the hepatobiliary system, with most reports describing primarily hepatocellular injury with elevations of […]

Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis

Abstract: Alcohol-related liver disease is a spectrum of disease in which continued, significant alcohol use can cause progression from fatty changes in the liver to inflammation, […]

Cessation of Nucleoside/Nucleotide Analogue Therapy in Chronic Hepatitis B HBeAg-Negative Patients

Abstract: Most patients treated for chronic hepatitis B infection require lifelong treatment with nucleoside/nucleotide analogues (NAs), which inhibit hepatitis B virus (HBV) replication but do not […]

Helicobacter pylori Treatment Regimens: A US Perspective

Abstract: Helicobacter pylori infects nearly one-third of the US population. H pylori is a significant cause of gastroduodenal disease, including peptic ulcers and cancers. However, rising […]

Single-Use Duodenoscopes for ERCP: Rationale, Feasibility, Cost, and Environmental Impact

Abstract: Recent outbreaks of duodenoscope-associated multidrug-resistant organism infections have increased awareness and concern about the pitfalls in high-level disinfection protocols and duodenoscope design. A call for […]

Shooting for the Stars: Review of the STARDUST Trial and the Treat-to-Target Approach for Crohn’s Disease

Abstract: Crohn’s disease (CD) and ulcerative colitis, collectively termed inflammatory bowel disease, are progressive autoimmune conditions of the gastrointestinal tract. Mucosal healing has been associated with […]

Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease

Abstract: The armamentarium of medical therapy for inflammatory bowel disease (IBD) has expanded significantly during the past decade. A major change has been the introduction of […]

The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders

Gastroenterology & Hepatology February 2017, Volume 13, Issue 2 Brian P. Ciampa, MD, Emmanuel Reyes Ramos, MD, Marie Borum, MD, EdD, MPH, and David B. Doman, […]

Medical Management of Metabolic Complications of Liver Transplant Recipients

Gastroenterology & Hepatology October 2016, Volume 12, Issue 10 Abbey Barnard, MD, MPH, Peter Konyn, BS, and Sammy Saab, MD, MPH Dr Barnard is a resident […]

Management of Clostridium difficile Infection

Gastroenterology & Hepatology October 2016, Volume 12, Issue 10 Layth S. Al-Jashaami, MD, and Herbert L. DuPont, MD Dr Al-Jashaami is a clinical assistant professor at […]

The Cost-Effectiveness of Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature

Gastroenterology & Hepatology October 2016, Volume 12, Issue 10 Yecheskel Schneider, MD, Monica Saumoy, MD, Shirley Cohen-Mekelburg, MD, Adam F. Steinlauf, MD, and Ellen J. Scherl, MD […]

Sofosbuvir and Simeprevir Combination Therapy for HCV Genotype 1 Infection: Results of a Single-Center VA Experience

Gastroenterology & Hepatology Volume 12, Issue 8, August 2016 Seth N. Sclair, MD, Maria Del Pilar Hernandez, MD, Evan Vance, MS, Dani Gilinski, MD, Helen Youtseff, […]